News & Events

News

September 3, 2020 – Banner Life Sciences Announces BAFIERTAM, a Novel Oral Fumarate Treatment for Relapsing Forms of Multiple Sclerosis, is Now Available in the U.S.

View full release as a pdf here:

Banner Announces Bafiertam Now Available

 


July 16, 2020 – Banner Life Sciences Announces Commercial Launch of BAFIERTAM, a Novel Oral Fumarate Treatment for Relapsing Forms of Multiple Sclerosis

View full release as a pdf here:

Banner Announces Bafiertam Now Available

 


April 30, 2020 – Banner Life Sciences Announces Final FDA Approval of BAFIERTAM for Multiple Sclerosis

View full release as a pdf here:

Banner Life Sciences Announces Final FDA Approval of BAFIERTAM

 


April 21, 2020 – Banner Life Sciences Receives Favorable Appellate Court Decision in Biogen Patent Infringement Dispute

View full release as a pdf here:

BLS Wins 4-21-2020 FINAL.pdf

 


January 09, 2020 – Banner Life Sciences Receives Favorable Ruling Against Biogen in Patent Infringement Challenge

View full release as a pdf here:

Banner Life Sciences Receives Favorable Ruling.pdf

 


July 23, 2019 – Banner Life Sciences Announces First Subject Enrolled in Randomized, Double-Blind Head-to-Head Study of Bafiertam and Tecfidera for Comparative Assessment of GI Tolerability

View full release as a pdf here:

Banner Announces Head-to-Head Study of BAFIERTAM .pdf

 


January 02, 2019 – Banner Receives FDA Tentative Approval for BAFIERTAM for the Treatment of Relapsing Forms of Multiple Sclerosis

View full release as a pdf here:

BAFIERTAM FDA Tentative Approval 01 02 2019.pdf

 


Events

MS Virtual 2020
8th Joint ACTRIMS/ECTRIMS Meeting
September 11-13, 2020